Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
LAP-H82F8 | Human | Biotinylated Human LAP (TGF-beta 1) (C33S) Protein, Fc,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
LAP-H5213 | Human | Human LAP (TGF-beta 1) Protein, Tag Free (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
LAP-H82Q6 | Human | Biotinylated Human LAP (TGF-beta 1) Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
LAP-H5245 | Human | Human LAP (TGF-beta 1) Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized Human LAP (TGF-beta 1), Tag Free (Cat. No. LAP-H5213) at 1 μg/mL (100 μL/well) can bind Human ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT8-H52W4) with a linear range of 5-39 ng/mL (QC tested).
The purity of Biotinylated Human LAP (TGF-beta 1) (C33S), Fc,Avitag (Cat. No. LAP-H82F8) is more than 90% and the molecular weight of this protein is around 129-157 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Tonogenchoncel-L | TG-C | Approved | Tissuegene | Invossa-K, Invossa | South Korea | Osteoarthritis | null | 2017-07-01 | Intervertebral Disc Degeneration; Osteoarthritis, Knee; Osteoarthritis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Vactosertib | TEW-7197; EW-7197; NOV-1301 | Phase 3 Clinical | Medpacto Inc | Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma, Transitional Cell; Myelodysplastic Syndromes; Myeloproliferative Disorders; Osteosarcoma; Colorectal Neoplasms; Urologic Neoplasms; Esophageal adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma; Adenocarcinoma | Details |
Bintrafusp alfa | M-7824; GSK-4045154; MSB-0011359C | Phase 3 Clinical | Merck Serono | Brain metastases; Cholangiocarcinoma; Breast Neoplasms; Microsatellite Instability; Vulvar Neoplasms; Sarcoma; Nasopharyngeal Carcinoma; Prostatic Neoplasms; Colorectal Neoplasms; Thymus Neoplasms; Oropharyngeal Neoplasms; Gallbladder Neoplasms; Lung Neoplasms; Prostatic Neoplasms, Castration-Resistant; Lymphoma; Penile Neoplasms; Thymoma; Urogenital Neoplasms; Metastatic breast cancer; Carcinoma, Small Cell; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma; Neoplasm Metastasis; Sarcoma, Kaposi; Neoplasms, Germ Cell and Embryonal; Stomach Neoplasms; Solid tumours; Hematologic Neoplasms; Head and Neck Neoplasms; Intestinal Neoplasms; Skin Melanoma; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Vaginal Neoplasms; Carcinoma; Carcinoma, Renal Cell; Esthesioneuroblastoma, Olfactory; Anus Neoplasms; Biliary Tract Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Nose Neoplasms; Ganglioglioma; Papillomavirus Infections; Carcinoma, Trans | Details |
Nisevokitug | NIS-793 | Phase 3 Clinical | Xoma Corp | Kidney Neoplasms; Polycythemia Vera; Pancreatic Neoplasms; Myelodysplastic Syndromes; Breast Neoplasms; Colorectal Neoplasms; Primary Myelofibrosis; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Adenocarcinoma; Thrombocythemia, Essential; Carcinoma, Hepatocellular | Details |
SB-01 (Ensol BioSciences) | Peniel-2000; SB-01; Peniel 2K; YH14618; YH-14618; P2K | Phase 3 Clinical | Ensol Biosciences Inc | Intervertebral Disc Degeneration; Intervertebral disc disease; Low Back Pain | Details |
Livmoniplimab | MGH-8; AGRX-115; ABBV-151; MHG-8; ARGX-115 | Phase 3 Clinical | Argenx Se | Solid tumours; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular | Details |
Dalutrafusp alfa | GS-1423; AGEN-1423 | Phase 2 Clinical | Agenus Inc | Solid tumours; Liver Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal | Details |
ZSP-1603 | ZSP-1603 | Phase 2 Clinical | Wuxi Apptec Co Ltd, Guangdong Zhongsheng Pharmaceutical Co Ltd | Ovarian Neoplasms; Liver Neoplasms; Solid tumours; Carcinoma, Renal Cell; Idiopathic Pulmonary Fibrosis; Colonic Neoplasms; Thyroid Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
Nicousamide | XLF-III-43 | Phase 2 Clinical | Institue Of Materia Medica Chinese Academy Of Medical Science | Hypertensive nephropathy; Diabetic Nephropathies | Details |
Meflonidone hydrochloride | Phase 2 Clinical | Guangzhou Nanxin Pharma Co Ltd, Central South University | Diabetes Mellitus, Type 2; Diabetic Nephropathies | Details | |
Fluorofenidone | AKF-PD | Phase 2 Clinical | Dierepharma HK Ltd, Hainan Haiyao Co Ltd, Central South University | Liver Cirrhosis | Details |
Cotsiranib | STP-705LU; STP-705LV; STP-705; STP-705L | Phase 2 Clinical | Sirnaomics, Sirnaomics Biopharmaceuticals (Suzhou) Co Ltd | Liver Neoplasms; Carcinoma, Basal Cell; Cholangiocarcinoma; Carcinoma, Basosquamous; Obesity, Abdominal; Keloid; Cicatrix, Hypertrophic; Carcinoma, Hepatocellular | Details |
Yinfenidone Hydrochloride | HEC-585; HEC-00000585 | Phase 2 Clinical | Hec Pharm Co Ltd | Idiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis | Details |
YL-13027 | YL-13027 | Phase 2 Clinical | YL-Pharma | Solid tumours; Pancreatic Neoplasms | Details |
Linavonkibart | SRK-181; SRT-BETA-1-AB3 | Phase 1 Clinical | Scholar Rock | Neoplasms | Details |
Charis-1000 | Charis-1000; C 1K; C1K | Phase 1 Clinical | Ensol Biosciences Inc | Breast Neoplasms | Details |
HLX-6018 | HLX-6018; HLX6018 | Phase 1 Clinical | Shanghai Henlius Biopharmaceuticals Co Ltd, Shanghai Henlius Biotech Inc | Idiopathic Pulmonary Fibrosis | Details |
RO7496353 | RO7496353; RO-7496353; SOF 10; RG6440; RG-6440 | Phase 1 Clinical | Genentech Inc | Solid tumours; Stomach Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung | Details |
JYB-1907 | JYB-1907 | Phase 1 Clinical | Jiangxi Jemincare Group Co Ltd | Solid tumours | Details |
STP-707 | STP-707; STP707 | Phase 1 Clinical | Sirnaomics Biopharmaceuticals (Suzhou) Co Ltd | Liver Neoplasms; Solid tumours; Pancreatic Neoplasms; Liver Cirrhosis; Pulmonary Fibrosis; Cholangitis, Sclerosing | Details |
PXS-64 | PXS-64 | Phase 1 Clinical | Syntara Ltd | Multiple Sclerosis | Details |
AVID-200 | AVID-200; BMS-986416; AVID-200 DP | Phase 1 Clinical | Formation Biologics Corp | Solid tumours; Polycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Thrombocythemia, Essential | Details |
This web search service is supported by Google Inc.